A Test of Iron Malabsorption in Patients With Iron Deficiency Anemia
NCT00399191 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2010-03-18
Summary
The objective of the study is to develop a simple, noninvasive test for evaluation of iron absorption as a tool to determine the cause of iron deficiency anemia. Healthy, premenopausal women with iron deficiency with or without anemia will be recruited for the study. Participants will, over the course of two months, ingest an iron solution three times; after each iron ingestion, participants will collect their stool and bring it to the study investigators for assessment of iron content.
Conditions
Interventions
- DRUG
-
stable isotope of iron, dysprosium
Sponsors & Collaborators
-
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
lead NIH
Principal Investigators
-
Morteza Janghorbani, PhD · BioChemAnalysis Corp.
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- DIAGNOSTIC
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 20 Years
- Max Age
- 40 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2006-08-31
Countries
- United States
Study Locations
More Related Trials
-
Clinical and Laboratory Investigation of Humans With Informative Iron or Erythroid Phenotypes
NCT00102245 ·Status: TERMINATED
-
Pharmacokinetics, Pharmacodynamics and Safety Study of Z-213 to Iron Deficiency Anemia
NCT02170311 ·Status: COMPLETED ·Phase: PHASE1
-
Measurements of Body Iron Excretion of Healthy Adults
NCT00755105 ·Status: COMPLETED
-
Iron Replacement in Blood Donors
NCT00327067 ·Status: COMPLETED
-
Effect of Iron Status on Occurrence of Non-transferrin-bound Iron (NTBI) in Serum in Response to an Oral Iron Load
NCT02831712 ·Status: UNKNOWN ·Phase: NA
-
Substitution of the Normal Levels of Iron and Hemoglobin in Pregnant Women With Iron Supplement
NCT02957643 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose vs Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
NCT03238911 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of Subcutaneous Desferrioxamine as Treatment for Transfusional Hemochromatosis
NCT00000595 ·Status: COMPLETED ·Phase: PHASE2
-
Ferritin as a Predictor for Anemia in Pregnancy
NCT03565198 ·Status: UNKNOWN
-
Low-dose Iron Supplementation and Markers of Iron Status Among Non-anemic, Iron-deficient Women
NCT02683369 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Safety and Acceptability of Deferiprone Delayed Release Tablets in Patients With Systemic Iron Overload
NCT03802916 ·Status: COMPLETED ·Phase: PHASE2
-
A Study Comparing the Iron Substitution With the Medicinal Products Ferinject or Monofer
NCT02905539 ·Status: COMPLETED ·Phase: PHASE4
-
Assessing the Immediate Increase in Serum Ferritin After Oral Iron Doses: an Experimental Study in Iron-deficient Women
NCT06851130 ·Status: RECRUITING ·Phase: NA
-
Study of Deferasirox for Treatment of Transfusional Iron Overload in Myelodysplastic Patients
NCT00110266 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of the Safety and Efficacy of Intravenous Iron Versus Oral Iron in the Treatment of Anemia Secondary to Heavy Uterine Bleeding
NCT00395993 ·Status: COMPLETED ·Phase: PHASE3
-
Intravenous Iron Isomaltoside Versus Oral Iron Supplementation for Treatment of Iron Deficiency in Pregnancy.
NCT03188445 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of Iron Injection on Blood Donation
NCT03014921 ·Status: UNKNOWN ·Phase: NA
-
Relative Contributions of Red Cell Catabolism and Dietary Absorption to Fetal Iron Accretion During Pregnancy
NCT01588665 ·Status: COMPLETED
-
Clinical Study of Z-213 in Subjects With Iron-deficiency Anemia
NCT02828319 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Tolerability of Ferric Carboxymaltose (FCM) Versus Standard of Care in Treating Iron Deficiency Anemia
NCT00703937 ·Status: COMPLETED ·Phase: PHASE3
-
Randomized Placebo-controlled Trial of FCM as Treatment for Heart Failure With Iron Deficiency / and Sub-Study
NCT03037931 ·Status: COMPLETED ·Phase: PHASE3
-
Extension Study of Iron Chelation Therapy With Deferasirox in β-thalassemia and Rare Chronic Anemia Patients
NCT00303329 ·Status: COMPLETED ·Phase: PHASE2
-
Incidence of Hypophosphatemia After Treatment With Iron Isomaltoside/Ferric Derisomaltose or Ferric Carboxymaltose in Subjects With Iron Deficiency Anaemia
NCT03237065 ·Status: COMPLETED ·Phase: PHASE3
-
A Trial Comparing Ferumoxytol With Placebo for the Treatment of Iron Deficiency Anemia
NCT01114139 ·Status: COMPLETED ·Phase: PHASE3
-
Trial To Evaluate the Efficacy of Intravenous Iron in Older Adults With Unexplained Anemia
NCT01309659 ·Status: TERMINATED ·Phase: PHASE2